Harmonizing Clinical Endpoints in Dermatology: Bridging Science, Industry, and Regulatory Requirements
Time: 9:30 am
day: Day Two
Details:
- Navigate the complexities of endpoint selection across global markets, examining the disconnect between US IGA and European EASI scoring systems
- Evaluate the challenges of subjective measurements like pruritus in clinical trials, and their evolving role as primary vs secondary endpoints
- Explore strategies for designing trials that balance scientific rigor with pragmatic industry needs while meeting diverse regulatory requirements
